Updated Apr 4, 2007 at 7:4 EST.
The Food and Drug Administration ( FDA ) is trying to “crack down” on the amount of off-label prescription drugs that doctors use to treat conditions that the drugs were not approved to treat. Premature ejaculation ( PE ) is one condition where there are no specific drug treatments and an area where investigators feel that too many off-label drugs are prescribed. The FDA notes that many doctors receive information about potential off-label uses during face-to-face conversations with sales representatives for pharmaceutical companies.
Other critics urge the FDA to enforce strict prescribing information since many of these medications are marketed toward otherwise healthy individuals. For example, individuals with premature ejaculation ( PE ) are otherwise healthy, even though the condition does cause quite a bit of dissatisfaction and anxiety with sexual performance. One attorney who handles consumer fraud causes says, “off-label promotion of drugs is a form of quackery that victimizes vulnerable individuals who take these drugs with serious and dangerous side effects for purposes never intended.”
Written by the PEhomepage.com Editorial Team.
Back to Articles 
Latest News Archive 
E-mail a Friend
